MARIA SUAREZ-ALMAZOR to Palliative Care
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Palliative Care.
Connection Strength
0.361
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6119-6128.
Score: 0.084
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6159-6173.
Score: 0.084
-
Cost effectiveness in palliative care. Palliat Med. 1998 Sep; 12(5):315-6.
Score: 0.073
-
Clinical and ethical questions concerning delirium study on patients with advanced cancer. Arch Intern Med. 2001 Jan 22; 161(2):296-9.
Score: 0.043
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Support Care Cancer. 2020 Dec; 28(12):6145-6157.
Score: 0.021
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6129-6143.
Score: 0.021
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities. Support Care Cancer. 2020 Dec; 28(12):6175-6181.
Score: 0.021
-
The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage. 1994 Nov; 9(8):515-9.
Score: 0.014